Timothy Brown, M.D. Titles and Appointments Assistant Professor School Medical School Department Internal Medicine You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Timothy J Brown, MD MSCE, is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Hematology and Oncology. He specializes in the treatment of gastrointestinal cancers. Originally from Florida, Dr. Brown holds a bachelor's degree in human nutrition, foods, and exercise from Virginia Polytechnic Institute and State University (Virginia Tech) in Blacksburg, Virginia. He earned his medical degree at the Pennsylvania State University College of Medicine in Hershey, Pennsylvania, and completed internal medicine residency training at UT Southwestern, where he served as Chief Resident. He gained advanced training in hematology and oncology through a fellowship at the Hospital of the University of Pennsylvania, where he served as Chief Fellow and also earned a master’s degree in clinical epidemiology. Certified by the American Board of Internal Medicine, Dr. Brown joined the UT Southwestern faculty in 2023. A prolific author and researcher, Dr. Brown has an interest in early phase clinical trial design and outcomes research for gastrointestinal malignancies. He has published numerous articles in peer-reviewed journals and serves as an ad hoc reviewer for several journals, including Annals of Internal Medicine, Journal of Clinical Oncology, and JAMA Oncology. He is an active member of the American Society of Clinical Oncology In 2023, Dr. Brown earned the Conquer Cancer Merit Award at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. Personal Note When he’s not at work, Dr. Brown enjoys lifting weights and spending time with his family. Education Medical School Pennsylvania State University College of Medicine (2015) Residency UT Southwestern Medical Center (2019), Internal Medicine Fellowship Hospital of the University of Pennsylvania (2023), Hematology Oncology Graduate School University of Pennsylvania Perelman School of Medicine (2023), Clinical Epidemiology Research Interest Acute Leukemias and Lymphoma Bone Marrow Transplantation Quality Improvement Publications Featured Publications Outcomes of Patients With Esophageal and Gastric Carcinoma at a Safety-net Health Care System: A Juncture to Explore Disparities in Diverse Socioeconomic Cohorts and Ethnicities. Narra K, Guthula S, Teigen KJ, Potti S, Bullock JC, Brown TJ, Am J Clin Oncol 2025 Dec A Real-World, Propensity-Matched Analysis of Second-Line FOLFIRI-Ramucirumab Versus Ramucirumab-Paclitaxel in Patients With Advanced Upper Gastrointestinal Cancers. Hyak JM, Ruan P, Jones AL, Verma N, Chung V, Grewal US, Vadehra D, Hornstein N, Wang SC, Porembka MR, Badiyan S, Sanford NN, Kazmi S, Brown TJ, Am J Clin Oncol 2025 Dec Bridging Knowledge Gaps in the Treatment of Advanced Hepatocellular Carcinoma. Brown TJ, JAMA Netw Open 2025 Dec 8 12 e2551674 Treat the Tumor, Spare the Esophagus: The Case for Organ Preservation in Locally Advanced Esophageal/Gastroesophageal Junction Cancer. Grewal US, Sanford NN, Brown TJ, J Clin Oncol 2025 Sep JCO2501197 New Tool in the Toolbox: Patient Selection for Zolbetuximab in Advanced Treatment-Naïve Gastric/Gastroesophageal Junction Adenocarcinoma. Grewal US, Brown TJ, Oncologist 2025 Jun Evaluating the Safety and Efficacy of Adding Liver-Directed Radiation Therapy to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: A Single-Center Retrospective Cohort Analysis. Brown TJ, Amit U, Gheewala R, Ben-Josef E, Karasic TB, Am J Clin Oncol 2025 Apr Impact of Screening on Mortality for Patients Diagnosed with Hepatocellular Carcinoma in a Safety-Net Healthcare System: An Opportunity for Addressing Disparities. Narra K, Hull M, Teigen KJ, Reddy V, Bullock JC, Basha R, Alawi-Kakomanolis N, Gerber DE, Brown TJ, Cancers (Basel) 2024 Nov 16 22 Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab. Brown TJ, Gimotty PA, Mamtani R, Karasic TB, Yang YX, JCO Clin Cancer Inform 2024 Aug 8 e2300220 The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 After Progression on Rucaparib. Brown TJ, Yablonovitch A, Till JE, Yen J, Kiedrowski LA, Hood R, O'Hara MH, Teitelbaum U, Karasic TB, Schneider C, Carpenter EL, Nathanson K, Domchek SM, Reiss KA, Clin Cancer Res 2023 Jul Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis. Brown TJ, Mamtani R, Gimotty PA, Karasic TB, Yang YX, J Cancer Res Clin Oncol 2023 Jun 149 6 2345-2354 Results 1-10 of 34 1 2 3 4 Next Last Honors & Awards DocstarsCary Council (2025) Conquer Cancer Merit AwardAmerican Society of Clinical Oncology (2023) Conquer Cancer Merit AwardAmerican Society of Clinical Oncology (2022) Chief Fellow, Hematology & OncologyHospital of the University of Pennsylvania (2021) Top ReviewerAnnals of Internal Medicine (2021) Outstanding Recent AlumniCollege of Agriculture and Life Sciences, Virginia Tech (2019) Chief ResidentUT Southwestern Medical Center (2018) Top ReviewerAnnals of Internal Medicine (2018) Professional Associations/Affiliations American Society of Clinical Oncology
